menu search

Caribou Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Caribou Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
— CB-010 ANTLER Phase 1 trial in r/r B-NHL ongoing with update planned for H2 2023 — — CB-011 CaMMouflage Phase 1 trial in r/r MM recruiting patients at dose level 1 — — CB-012 IND-enabling studies initiated; IND submission in r/r AML planned for H2 2023 — — $317.0 million in cash, cash equivalents, […] The post Caribou Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update appeared first on ForexTV... Read More
Posted: Mar 9 2023, 22:09
Author Name: forextv
Views: 102037

Search within

Pages Search Results: